MSInsight bioinformatics start-up that develops diagnostic and treatment response prediction solutions for MSI cancers.
MSInsight has raised $1.7M in total funding. The most recent round was Seed. The last funding was announced in March 2025.
MSInsight's investors include Bpifrance, Capital Cell, AGORANOV, Calyseed, YES invest.
MSInsight is headquartered in Paris, France.
MSInsight bioinformatics start-up that develops diagnostic and treatment response prediction solutions for MSI cancers.
MSInsight is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MSInsight — Funding & Investors." VCBacked, March 10, 2025, https://www.vcbacked.co/company/msinsight. Accessed September 15, 2026.
VCBacked. (2025). MSInsight — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/msinsight
{{cite web |title=MSInsight — Funding & Investors |url=https://www.vcbacked.co/company/msinsight |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated